A year after announcing its decision to exit stem cell therapy, Geron Corporation (GERN) announced that it has entered into a non-binding letter of intent (:LOI) with BioTime, Inc. (BTX) and BioTime`s ...
The use of the GMP grade cell lines may streamline the translation of basic science to human therapies. Should the users of the cell lines and BioTime eventually sign definitive license agreements for ...
BioTime, Inc. announced an agreement with the California Institute for Regenerative Medicine (CIRM) to make five clinical-grade human Embryonic Stem (hES) cell lines available to California-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results